Pivotal Importance of STAT3 in Protecting the Heart from Acute and Chronic Stress: New Advancement and Unresolved Issues

Frontiers in Cardiovascular Medicine

Volumn 2, Issue , 2015, Pages

  Zouein, Fouad A ^a   Altara, Raffaele ^b   Chen, Qun ^c   Lesnefsky, Edward J ^c,d   Kurdi, Mazen ^b,e   Booz, George W ^b  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e LEBANESE UNIVERSITY   (Lebanon)

Author keywords

cardiac hypertrophy; complex I; heart failure; ischemic pre and post conditioning; mitochondria; myocardial infarction; peripartum cardiomyopathy; U STAT3

Indexed keywords

EID: 84960424658     PISSN: None     EISSN: 2297055X     Source Type: Journal    
DOI: 10.3389/fcvm.2015.00036     Document Type: Review

References (171)

1. Zouein FA, Kurdi M, Booz GW. Dancing rhinos in stilettos: the amazing saga of the genomic and nongenomic actions of STAT3 in the heart. JAKSTAT (2013) 2:e24352.10.4161/jkst.2435224069556
2. Kurdi M, Booz GW. JAK redux: a second look at the regulation and role of JAKs in the heart. Am J Physiol Heart Circ Physiol (2009) 297:H1545–56.10.1152/ajpheart.00032.200919717737
3. Kurdi M, Booz GW. Can the protective actions of JAK-STAT in the heart be exploited therapeutically? Parsing the regulation of interleukin-6-type cytokine signaling. J Cardiovasc Pharmacol (2007) 50:126–41.10.1097/FJC.0b013e318068dd4917703129
4. Szczepanek K, Lesnefsky EJ, Larner AC. Multi-tasking: nuclear transcription factors with novel roles in the mitochondria. Trends Cell Biol (2012) 22:429–37.10.1016/j.tcb.2012.05.00122705015
5. Szczepanek K, Chen Q, Larner AC, Lesnefsky EJ. Cytoprotection by the modulation of mitochondrial electron transport chain: the emerging role of mitochondrial STAT3. Mitochondrion (2012) 12:180–9.10.1016/j.mito.2011.08.01121930250
6. Das A, Salloum FN, Filippone SM, Durrant DE, Rokosh G, Bolli R, et al. Inhibition of mammalian target of rapamycin protects against reperfusion injury in diabetic heart through STAT3 signaling. Basic Res Cardiol (2015) 110:31.10.1007/s00395-015-0486-525911189
7. Drenger B, Ostrovsky IA, Barak M, Nechemia-Arbely Y, Ziv E, Axelrod JH. Diabetes blockade of sevoflurane postconditioning is not restored by insulin in the rat heart: phosphorylated signal transducer and activator of transcription 3- and phosphatidylinositol 3-kinase-mediated inhibition. Anesthesiology (2011) 114:1364–72.10.1097/ALN.0b013e31820efafd21368653
8. Boengler K, Buechert A, Heinen Y, Roeskes C, Hilfiker-Kleiner D, Heusch G, et al. Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice. Circ Res (2008) 102:131–5.10.1161/CIRCRESAHA.107.16469917967780
9. Boengler K, Hilfiker-Kleiner D, Drexler H, Heusch G, Schulz R. The myocardial JAK/STAT pathway: from protection to failure. Pharmacol Ther (2008) 120:172–85.10.1016/j.pharmthera.2008.08.00218786563
10. Podewski EK, Hilfiker-Kleiner D, Hilfiker A, Morawietz H, Lichtenberg A, Wollert KC, et al. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy. Circulation (2003) 107:798–802.10.1161/01.CIR.0000057545.82749.FF12591746
11. Cambi GE, Lucchese G, Djeokeng MM, Modesti A, Fiaschi T, Faggian G, et al. Impaired JAK2-induced activation of STAT3 in failing human myocytes. Mol Biosyst (2012) 8:2351–9.10.1039/c2mb25120e22735740
12. 1a-adrenergic receptor differentially regulates STAT3 phosphorylation through PKCЄ and PKCδ in myocytes. J Recept Signal Transduct Res (2012) 32:76–86.10.3109/10799893.2011.647353
13. Willey CD, Palanisamy AP, Johnston RK, Mani SK, Shiraishi H, Tuxworth WJ, et al. STAT3 activation in pressure-overloaded feline myocardium: role for integrins and the tyrosine kinase BMX. Int J Biol Sci (2008) 4:184–99.10.7150/ijbs.4.18418612371
14. Frias MA, James RW, Gerber-Wicht C, Lang U. Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate. Cardiovasc Res (2009) 82:313–23.10.1093/cvr/cvp02419151362
15. Wu G, Liu Y, Huang H, Tang Y, Liu W, Mei Y, et al. SH2B1 is critical for the regulation of cardiac remodelling in response to pressure overload. Cardiovasc Res (2015) 107:203–15.10.1093/cvr/cvv17026077624
16. Matsui H, Yokoyama T, Tanaka C, Sunaga H, Koitabashi N, Takizawa T, et al. Pressure mediated hypertrophy and mechanical stretch up-regulate expression of the long form of leptin receptor (ob-Rb) in rat cardiac myocytes. BMC Cell Biol (2012) 13:37.10.1186/1471-2121-13-3723270329
17. Qiu H, Lizano P, Laure L, Sui X, Rashed E, Park JY, et al. H11 kinase/heat shock protein 22 deletion impairs both nuclear and mitochondrial functions of STAT3 and accelerates the transition into heart failure on cardiac overload. Circulation (2011) 124:406–15.10.1161/CIRCULATIONAHA.110.01384721747053
18. Miyamoto T, Takeishi Y, Takahashi H, Shishido T, Arimoto T, Tomoike H, et al. Activation of distinct signal transduction pathways in hypertrophied hearts by pressure and volume overload. Basic Res Cardiol (2004) 99:328–37.10.1007/s00395-004-0482-715309410
19. Uozumi H, Hiroi Y, Zou Y, Takimoto E, Toko H, Niu P, et al. gp130 plays a critical role in pressure overload-induced cardiac hypertrophy. J Biol Chem (2001) 276:23115–9.10.1074/jbc.M10081420011262406
20. Pan J, Fukuda K, Kodama H, Sano M, Takahashi T, Makino S, et al. Involvement of gp130-mediated signaling in pressure overload-induced activation of the JAK/STAT pathway in rodent heart. Heart Vessels (1998) 13:199–208.10.1007/BF0174504510442402
21. Pan J, Fukuda K, Saito M, Matsuzaki J, Kodama H, Sano M, et al. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes. Circ Res (1999) 84:1127–36.10.1161/01.RES.84.10.112710347087
22. Pan J, Fukuda K, Kodama H, Makino S, Takahashi T, Sano M, et al. Role of angiotensin II in activation of the JAK/STAT pathway induced by acute pressure overload in the rat heart. Circ Res (1997) 81:611–7.10.1161/01.RES.81.4.6119314843
23. Booz GW, Day JN, Baker KM. Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure. J Mol Cell Cardiol (2002) 34:1443–53.10.1006/jmcc.2002.207612431443
24. Sano M, Fukuda K, Kodama H, Pan J, Saito M, Matsuzaki J, et al. Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J Biol Chem (2000) 275:29717–23.10.1074/jbc.M00312820010843995
25. Tsai CT, Lai LP, Kuo KT, Hwang JJ, Hsieh CS, Hsu KL, et al. Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts: implication for the therapeutic effect of statin in atrial structural remodeling. Circulation (2008) 117:344–55.10.1161/CIRCULATIONAHA.107.69534618172037
26. Zouein FA, Zgheib C, Hamza S, Fuseler JW, Hall JE, Soljancic A, et al. Role of STAT3 in angiotensin II-induced hypertension and cardiac remodeling revealed by mice lacking STAT3 serine 727 phosphorylation. Hypertens Res (2013) 36:496–503.10.1038/hr.2012.22323364341
27. Iwasaki H, Kovacic JC, Olive M, Beers JK, Yoshimoto T, Crook MF, et al. Disruption of protein arginine N-methyltransferase 2 regulates leptin signaling and produces leanness in vivo through loss of STAT3 methylation. Circ Res (2010) 107:992–1001.10.1161/CIRCRESAHA.110.22532620798359
28. Dasgupta M, Dermawan JK, Willard B, Stark GR. STAT3-driven transcription depends upon the dimethylation of K49 by EZH2. Proc Natl Acad Sci U S A (2015) 112:3985–90.10.1073/pnas.150315211225767098
29. 2-terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen. Gastroenterology (2005) 129:1616–32.10.1053/j.gastro.2005.07.05516285960
30. 2-terminal domain stabilizes enhanceosome assembly by interacting with the p300 bromodomain. J Biol Chem (2008) 283:30725–34.10.1074/jbc.M80594120018782771
31. Ray S, Lee C, Hou T, Boldogh I, Brasier AR. Requirement of histone deacetylase1 (HDAC1) in signal transducer and activator of transcription 3 (STAT3) nucleocytoplasmic distribution. Nucleic Acids Res (2008) 36:4510–20.10.1093/nar/gkn41918611949
32. Icardi L, Mori R, Gesellchen V, Eyckerman S, De Cauwer L, Verhelst J, et al. The Sin3a repressor complex is a master regulator of STAT transcriptional activity. Proc Natl Acad Sci U S A (2012) 109:12058–63.10.1073/pnas.120645810922783022
33. 2 terminal mono-ubiquitination promotes BRD4 complex formation to regulate apoptosis. Cell Signal (2014) 26:1445–55.10.1016/j.cellsig.2014.03.00724657799
34. Yang J, Huang J, Dasgupta M, Sears N, Miyagi M, Wang B, et al. Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes. Proc Natl Acad Sci U S A (2010) 107:21499–504.10.1073/pnas.101614710721098664
35. Kim E, Kim M, Woo DH, Shin Y, Shin J, Chang N, et al. Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. Cancer Cell (2013) 23:839–52.10.1016/j.ccr.2013.04.00823684459
36. Kim J, Won JS, Singh AK, Sharma AK, Singh I. STAT3 regulation by S-nitrosylation: implication for inflammatory disease. Antioxid Redox Signal (2014) 20:2514–27.10.1089/ars.2013.522324063605
37. Nie Y, Erion DM, Yuan Z, Dietrich M, Shulman GI, Horvath TL, et al. STAT3 inhibition of gluconeogenesis is downregulated by SirT1. Nat Cell Biol (2009) 11:492–500.10.1038/ncb185719295512
38. Ray S, Sherman CT, Lu M, Brasier AR. Angiotensinogen gene expression is dependent on signal transducer and activator of transcription 3-mediated p300/cAMP response element binding protein-binding protein coactivator recruitment and histone acetyltransferase activity. Mol Endocrinol (2002) 16:824–36.10.1210/mend.16.4.081111923478
39. Wang R, Cherukuri P, Luo J. Activation of Stat3 sequence-specific DNA binding and transcription by p300/CREB-binding protein-mediated acetylation. J Biol Chem (2005) 280:11528–34.10.1074/jbc.M41393020015649887
40. Lee H, Zhang P, Herrmann A, Yang C, Xin H, Wang Z, et al. Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation. Proc Natl Acad Sci U S A (2012) 109:7765–9.10.1073/pnas.120513210922547799
41. Thomas NS. The STAT3-DNMT1 connection. JAKSTAT (2012) 1:257–60.10.4161/jkst.2243624058781
42. Dasgupta M, Unal H, Willard B, Yang J, Karnik SS, Stark GR. Critical role for lysine 685 in gene expression mediated by transcription factor unphosphorylated STAT3. J Biol Chem (2014) 289:30763–71.10.1074/jbc.M114.60389425217633
43. Waitkus MS, Chandrasekharan UM, Willard B, Tee TL, Hsieh JK, Przybycin CG, et al. Signal integration and gene induction by a functionally distinct STAT3 phosphoform. Mol Cell Biol (2014) 34:1800–11.10.1128/MCB.00034-1424615012
44. Schuringa JJ, Schepers H, Vellenga E, Kruijer W. Ser727-dependent transcriptional activation by association of p300 with STAT3 upon IL-6 stimulation. FEBS Lett (2001) 495:71–6.10.1016/S0014-5793(01)02354-711322950
45. Tammineni P, Anugula C, Mohammed F, Anjaneyulu M, Larner AC, Sepuri NB. The import of the transcription factor STAT3 into mitochondria depends on GRIM-19, a component of the electron transport chain. J Biol Chem (2013) 288:4723–32.10.1074/jbc.M112.37898423271731
46. Wegrzyn J, Potla R, Chwae YJ, Sepuri NB, Zhang Q, Koeck T, et al. Function of mitochondrial Stat3 in cellular respiration. Science (2009) 323:793–7.10.1126/science.1164551
47. Gough DJ, Koetz L, Levy DE. The MEK-ERK pathway is necessary for serine phosphorylation of mitochondrial STAT3 and Ras-mediated transformation. PLoS One (2013) 8:e83395.10.1371/journal.pone.008339524312439
48. Zhang Q, Raje V, Yakovlev VA, Yacoub A, Szczepanek K, Meier J, et al. Mitochondrial localized Stat3 promotes breast cancer growth via phosphorylation of serine 727. J Biol Chem (2013) 288:31280–8.10.1074/jbc.M113.50505724019511
49. Booz GW, Day JN, Baker KM. Angiotensin II effects on STAT3 phosphorylation in cardiomyocytes: evidence for Erk-dependent Tyr705 dephosphorylation. Basic Res Cardiol (2003) 98:33–8.10.1007/s00395-003-0387-x12494267
50. Ng IH, Bogoyevitch MA, Jans DA. Cytokine-induced slowing of STAT3 nuclear import; faster basal trafficking of the STAT3β isoform. Traffic (2014) 15:946–60.10.1111/tra.1218124903907
51. Zhang J, Yang J, Roy SK, Tininini S, Hu J, Bromberg JF, et al. The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3. Proc Natl Acad Sci U S A (2003) 100:9342–7.10.1073/pnas.163351610012867595
52. O’Shea JJ, Kanno Y, Chen X, Levy DE. Cell signaling. Stat acetylation – a key facet of cytokine signaling? Science (2005) 307:217–8.10.1126/science.1108164
53. Stark GR, Wang Y, Lu T. Lysine methylation of promoter-bound transcription factors and relevance to cancer. Cell Res (2011) 21:375–80.10.1038/cr.2010.17421151202
54. Komyod W, Bauer UM, Heinrich PC, Haan S, Behrmann I. Are STATS arginine-methylated? J Biol Chem (2005) 280:21700–5.10.1074/jbc.C40060620015826948
55. Xie Y, Kole S, Precht P, Pazin MJ, Bernier M. S-glutathionylation impairs signal transducer and activator of transcription 3 activation and signaling. Endocrinology (2009) 150:1122–31.10.1210/en.2008-124118988672
56. Butturini E, Darra E, Chiavegato G, Cellini B, Cozzolino F, Monti M, et al. S-Glutathionylation at Cys328 and Cys542 impairs STAT3 phosphorylation. ACS Chem Biol (2014) 9:1885–93.10.1021/cb500407d24941337
57. Li L, Shaw PE. A STAT3 dimer formed by inter-chain disulphide bridging during oxidative stress. Biochem Biophys Res Commun (2004) 322:1005–11.10.1016/j.bbrc.2004.08.01415336564
58. 2 signaling. Nat Chem Biol (2015) 11:64–70.10.1038/nchembio.169525402766
59. Li L, Cheung SH, Evans EL, Shaw PE. Modulation of gene expression and tumor cell growth by redox modification of STAT3. Cancer Res (2010) 70:8222–32.10.1158/0008-5472.CAN-10-089420807804
60. Kurdi M, Sivakumaran V, Duhe RJ, Aon MA, Paolocci N, Booz GW. Depletion of cellular glutathione modulates LIF-induced JAK1-STAT3 signaling in cardiac myocytes. Int J Biochem Cell Biol (2012) 44:2106–15.10.1016/j.biocel.2012.08.01622939972
61. Zgheib C, Kurdi M, Zouein FA, Gunter BW, Stanley BA, Zgheib J, et al. Acyloxy nitroso compounds inhibit LIF signaling in endothelial cells and cardiac myocytes: evidence that STAT3 signaling is redox-sensitive. PLoS One (2012) 7:e43313.10.1371/journal.pone.004331322905257
62. Zouein FA, Kurdi M, Booz GW. LIF and the heart: just another brick in the wall? Eur Cytokine Netw (2013) 24:11–9.10.1684/ecn.2013.033523661360
63. Smith RM, Suleman N, Lacerda L, Opie LH, Akira S, Chien KR, et al. Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning. Cardiovasc Res (2004) 63:611–6.10.1016/j.cardiores.2004.06.01915306216
64. Hilfiker-Kleiner D, Hilfiker A, Fuchs M, Kaminski K, Schaefer A, Schieffer B, et al. Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ Res (2004) 95:187–95.10.1161/01.RES.0000134921.50377.6115192020
65. Hilfiker-Kleiner D, Limbourg A, Drexler H. STAT3-mediated activation of myocardial capillary growth. Trends Cardiovasc Med (2005) 15:152–7.10.1016/j.tcm.2005.05.00216099380
66. Osugi T, Oshima Y, Fujio Y, Funamoto M, Yamashita A, Negoro S, et al. Cardiac-specific activation of signal transducer and activator of transcription 3 promotes vascular formation in the heart. J Biol Chem (2002) 277:6676–81.10.1074/jbc.M10824620011744720
67. Funamoto M, Fujio Y, Kunisada K, Negoro S, Tone E, Osugi T, et al. Signal transducer and activator of transcription 3 is required for glycoprotein 130-mediated induction of vascular endothelial growth factor in cardiac myocytes. J Biol Chem (2000) 275:10561–6.10.1074/jbc.275.14.1056110744750
68. Negoro S, Kunisada K, Fujio Y, Funamoto M, Darville MI, Eizirik DL, et al. Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase. Circulation (2001) 104:979–81.10.1161/hc3401.09594711524388
69. Bolli R, Stein AB, Guo Y, Wang OL, Rokosh G, Dawn B, et al. A murine model of inducible, cardiac-specific deletion of STAT3: its use to determine the role of STAT3 in the upregulation of cardioprotective proteins by ischemic preconditioning. J Mol Cell Cardiol (2011) 50:589–97.10.1016/j.yjmcc.2011.01.00221223971
70. Enomoto D, Obana M, Miyawaki A, Maeda M, Nakayama H, Fujio Y. Cardiac-specific ablation of the STAT3 gene in the subacute phase of myocardial infarction exacerbated cardiac remodeling. Am J Physiol Heart Circ Physiol (2015) 309:H471–80.10.1152/ajpheart.00730.201426055795
71. Koitabashi N, Bedja D, Zaiman AL, Pinto YM, Zhang M, Gabrielson KL, et al. Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models. Circ Res (2009) 105:12–5.10.1161/CIRCRESAHA.109.19841619520971
72. Oba T, Yasukawa H, Hoshijima M, Sasaki K, Futamata N, Fukui D, et al. Cardiac-specific deletion of SOCS-3 prevents development of left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol (2012) 59:838–52.10.1016/j.jacc.2011.10.88722361405
73. Nagata T, Yasukawa H, Kyogoku S, Oba T, Takahashi J, Nohara S, et al. Cardiac-specific SOCS3 deletion prevents in vivo myocardial ischemia reperfusion injury through sustained activation of cardioprotective signaling molecules. PLoS One (2015) 10:e0127942.10.1371/journal.pone.012794226010537
74. Hilfiker-Kleiner D, Shukla P, Klein G, Schaefer A, Stapel B, Hoch M, et al. Continuous glycoprotein-130-mediated signal transducer and activator of transcription-3 activation promotes inflammation, left ventricular rupture, and adverse outcome in subacute myocardial infarction. Circulation (2010) 122:145–55.10.1161/CIRCULATIONAHA.109.93312720585009
75. Zgheib C, Zouein FA, Kurdi M, Booz GW. Differential STAT3 signaling in the heart: impact of concurrent signals and oxidative stress. JAKSTAT (2012) 1:101–10.10.4161/jkst.1977623904970
76. Heusch G. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. Circ Res (2015) 116:674–99.10.1161/CIRCRESAHA.116.30534825677517
77. Goodman MD, Koch SE, Fuller-Bicer GA, Butler KL. Regulating RISK: a role for JAK-STAT signaling in postconditioning? Am J Physiol Heart Circ Physiol (2008) 295:H1649–56.10.1152/ajpheart.00692.200818708442
78. Fuglesteg BN, Suleman N, Tiron C, Kanhema T, Lacerda L, Andreasen TV, et al. Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusion. Basic Res Cardiol (2008) 103:444–53.10.1007/s00395-008-0728-x18500485
79. Skyschally A, Gent S, Amanakis G, Schulte C, Kleinbongard P, Heusch G. Across-species transfer of protection by remote ischemic preconditioning with species-specific myocardial signal transduction by reperfusion injury salvage kinase and survival activating factor enhancement pathways. Circ Res (2015) 117:279–88.10.1161/CIRCRESAHA.117.30687826058828
80. Heusch G, Musiolik J, Kottenberg E, Peters J, Jakob H, Thielmann M. STAT5 activation and cardioprotection by remote ischemic preconditioning in humans: short communication. Circ Res (2012) 110:111–5.10.1161/CIRCRESAHA.111.25955622116817
81. Somers SJ, Frias M, Lacerda L, Opie LH, Lecour S. Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection. Cardiovasc Drugs Ther (2012) 26:227–37.10.1007/s10557-012-6376-222392184
82. Cai ZP, Parajuli N, Zheng X, Becker L. Remote ischemic preconditioning confers late protection against myocardial ischemia-reperfusion injury in mice by upregulating interleukin-10. Basic Res Cardiol (2012) 107:277.10.1007/s00395-012-0277-122752341
83. Cai WF, Kang K, Huang W, Liang JL, Feng YL, Liu GS, et al. CXCR4 attenuates cardiomyocytes mitochondrial dysfunction to resist ischaemia-reperfusion injury. J Cell Mol Med (2015) 19:1825–35.10.1111/jcmm.1255425824297
84. Nishinakamura H, Minoda Y, Saeki K, Koga K, Takaesu G, Onodera M, et al. An RNA-binding protein αCP-1 is involved in the STAT3-mediated suppression of NF-κB transcriptional activity. Int Immunol (2007) 19:609–19.10.1093/intimm/dxm026
85. Lecour S, Suleman N, Deuchar GA, Somers S, Lacerda L, Huisamen B, et al. Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase). Circulation (2005) 112:3911–8.10.1161/CIRCULATIONAHA.105.58105816344382
86. Miura T, Tanno M. The mPTP and its regulatory proteins: final common targets of signalling pathways for protection against necrosis. Cardiovasc Res (2012) 94:181–9.10.1093/cvr/cvr30222072634
87. Boengler K, Hilfiker-Kleiner D, Heusch G, Schulz R. Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion. Basic Res Cardiol (2010) 105:771–85.10.1007/s00395-010-0124-120960209
88. Szczepanek K, Chen Q, Derecka M, Salloum FN, Zhang Q, Szelag M, et al. Mitochondrial-targeted signal transducer and activator of transcription 3 (STAT3) protects against ischemia-induced changes in the electron transport chain and the generation of reactive oxygen species. J Biol Chem (2011) 286:29610–20.10.1074/jbc.M111.22620921715323
89. Heusch G, Musiolik J, Gedik N, Skyschally A. Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion. Circ Res (2011) 109:1302–8.10.1161/CIRCRESAHA.111.25560421980124
90. Li J, Umar S, Iorga A, Youn JY, Wang Y, Regitz-Zagrosek V, et al. Cardiac vulnerability to ischemia/reperfusion injury drastically increases in late pregnancy. Basic Res Cardiol (2012) 107:271.10.1007/s00395-012-0271-722648276
91. Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell (2007) 128:589–600.10.1016/j.cell.2006.12.03617289576
92. Ricke-Hoch M, Bultmann I, Stapel B, Condorelli G, Rinas U, Sliwa K, et al. Opposing roles of Akt and STAT3 in the protection of the maternal heart from peripartum stress. Cardiovasc Res (2014) 101:587–96.10.1093/cvr/cvu01024448315
93. van Spaendonck-Zwarts KY, Posafalvi A, van den Berg MP, Hilfiker-Kleiner D, Bollen IA, Sliwa K, et al. Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy. Eur Heart J (2014) 35:2165–73.10.1093/eurheartj/ehu05024558114
94. Haghikia A, Missol-Kolka E, Tsikas D, Venturini L, Brundiers S, Castoldi M, et al. Signal transducer and activator of transcription 3-mediated regulation of miR-199a-5p links cardiomyocyte and endothelial cell function in the heart: a key role for ubiquitin-conjugating enzymes. Eur Heart J (2011) 32:1287–97.10.1093/eurheartj/ehq36920965886
95. Verma SK, Krishnamurthy P, Barefield D, Singh N, Gupta R, Lambers E, et al. Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-κB. Circulation (2012) 126:418–29.10.1161/CIRCULATIONAHA.112.11218522705886
96. Cheon H, Yang J, Stark GR. The functions of signal transducers and activators of transcriptions 1 and 3 as cytokine-inducible proteins. J Interferon Cytokine Res (2011) 31:33–40.10.1089/jir.2010.010021166594
97. Yue H, Li W, Desnoyer R, Karnik SS. Role of nuclear unphosphorylated STAT3 in angiotensin II type 1 receptor-induced cardiac hypertrophy. Cardiovasc Res (2010) 85:90–9.10.1093/cvr/cvp28519696070
98. Yang J, Liao X, Agarwal MK, Barnes L, Auron PE, Stark GR. Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFκB. Genes Dev (2007) 21:1396–408.10.1101/gad.1553707
99. Kurdi M, Booz GW. New take on the role of angiotensin II in cardiac hypertrophy and fibrosis. Hypertension (2011) 57:1034–8.10.1161/HYPERTENSIONAHA.111.172700
100. Timofeeva OA, Chasovskikh S, Lonskaya I, Tarasova NI, Khavrutskii L, Tarasov SG, et al. Mechanisms of unphosphorylated STAT3 transcription factor binding to DNA. J Biol Chem (2012) 287:14192–200.10.1074/jbc.M111.32389922378781
101. Yan SJ, Lim SJ, Shi S, Dutta P, Li WX. Unphosphorylated STAT and heterochromatin protect genome stability. FASEB J (2011) 25:232–41.10.1096/fj.10-16936720847228
102. Shi S, Larson K, Guo D, Lim SJ, Dutta P, Yan SJ, et al. Drosophila STAT is required for directly maintaining HP1 localization and heterochromatin stability. Nat Cell Biol (2008) 10:489–96.10.1038/ncb171318344984
103. Xu N, Emelyanov AV, Fyodorov DV, Skoultchi AI. Drosophila linker histone H1 coordinates STAT-dependent organization of heterochromatin and suppresses tumorigenesis caused by hyperactive JAK-STAT signaling. Epigenetics Chromatin (2014) 7:16.10.1186/1756-8935-7-1625177369
104. Hu X, Dutta P, Tsurumi A, Li J, Wang J, Land H, et al. Unphosphorylated STAT5A stabilizes heterochromatin and suppresses tumor growth. Proc Natl Acad Sci U S A (2013) 110:10213–8.10.1073/pnas.122124311023733954
105. Meyer T, Gavenis K, Vinkemeier U. Cell type-specific and tyrosine phosphorylation-independent nuclear presence of STAT1 and STAT3. Exp Cell Res (2002) 272:45–55.10.1006/excr.2001.540511740864
106. Liu L, McBride KM, Reich NC. STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-α3. Proc Natl Acad Sci U S A (2005) 102:8150–5.10.1073/pnas.0501643102
107. Cimica V, Chen HC, Iyer JK, Reich NC. Dynamics of the STAT3 transcription factor: nuclear import dependent on Ran and importin-β1. PLoS One (2011) 6:e20188.10.1371/journal.pone.002018821625522
108. Reich NC. STATs get their move on. JAKSTAT (2013) 2:e27080.10.4161/jkst.2708024470978
109. Yang J, Stark GR. Roles of unphosphorylated STATs in signaling. Cell Res (2008) 18:443–51.10.1038/cr.2008.4118364677
110. Ushijima R, Sakaguchi N, Kano A, Maruyama A, Miyamoto Y, Sekimoto T, et al. Extracellular signal-dependent nuclear import of STAT3 is mediated by various importin alphas. Biochem Biophys Res Commun (2005) 330:880–6.10.1016/j.bbrc.2005.03.06315809078
111. Ma J, Cao X. Regulation of Stat3 nuclear import by importin α5 and importin α7 via two different functional sequence elements. Cell Signal (2006) 18:1117–26.10.1016/j.cellsig.2005.06.016
112. Ma J, Zhang T, Novotny-Diermayr V, Tan AL, Cao X. A novel sequence in the coiled-coil domain of Stat3 essential for its nuclear translocation. J Biol Chem (2003) 278:29252–60.10.1074/jbc.M30419620012746441
113. Vogt M, Domoszlai T, Kleshchanok D, Lehmann S, Schmitt A, Poli V, et al. The role of the N-terminal domain in dimerization and nucleocytoplasmic shuttling of latent STAT3. J Cell Sci (2011) 124:900–9.10.1242/jcs.07252021325026
114. Sato N, Tsuruma R, Imoto S, Sekine Y, Muromoto R, Sugiyama K, et al. Nuclear retention of STAT3 through the coiled-coil domain regulates its activity. Biochem Biophys Res Commun (2005) 336:617–24.10.1016/j.bbrc.2005.08.14516140268
115. Bhattacharya S, Schindler C. Regulation of Stat3 nuclear export. J Clin Invest (2003) 111:553–9.10.1172/JCI1537212588893
116. Qi QR, Yang ZM. Regulation and function of signal transducer and activator of transcription 3. World J Biol Chem (2014) 5:231–9.10.4331/wjbc.v5.i2.23124921012
117. Nadiminty N, Lou W, Lee SO, Lin X, Trump DL, Gao AC. Stat3 activation of NF-κB p100 processing involves CBP/p300-mediated acetylation. Proc Natl Acad Sci U S A (2006) 103:7264–9.10.1073/pnas.0509808103
118. Lee H, Herrmann A, Deng JH, Kujawski M, Niu G, Li Z, et al. Persistently activated Stat3 maintains constitutive NF-κB activity in tumors. Cancer Cell (2009) 15:283–93.10.1016/j.ccr.2009.02.015
119. Cavaillon JM. Pro- versus anti-inflammatory cytokines: myth or reality. Cell Mol Biol (Noisy-le-grand) (2001) 47:695–702.11502077
120. Gough DJ, Corlett A, Schlessinger K, Wegrzyn J, Larner AC, Levy DE. Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science (2009) 324:1713–6.10.1126/science.117172119556508
121. Gough DJ, Marie IJ, Lobry C, Aifantis I, Levy DE. STAT3 supports experimental K-RasG12D-induced murine myeloproliferative neoplasms dependent on serine phosphorylation. Blood (2014) 124:2252–61.10.1182/blood-2013-02-48419625150294
122. Yu C, Huo X, Agoston AT, Zhang X, Theiss AL, Cheng E, et al. Mitochondrial STAT3 contributes to transformation of Barrett’s epithelial cells that express oncogenic Ras in a p53-independent fashion. Am J Physiol Gastrointest Liver Physiol (2015) 309:G146–61.10.1152/ajpgi.00462.201426045618
123. Phillips D, Reilley MJ, Aponte AM, Wang G, Boja E, Gucek M, et al. Stoichiometry of STAT3 and mitochondrial proteins: implications for the regulation of oxidative phosphorylation by protein-protein interactions. J Biol Chem (2010) 285:23532–6.10.1074/jbc.C110.15265220558729
124. Chen Q, Camara AK, Stowe DF, Hoppel CL, Lesnefsky EJ. Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion. Am J Physiol Cell Physiol (2007) 292:C137–47.10.1152/ajpcell.00270.200616971498
125. Chen Q, Hoppel CL, Lesnefsky EJ. Blockade of electron transport before cardiac ischemia with the reversible inhibitor amobarbital protects rat heart mitochondria. J Pharmacol Exp Ther (2006) 316:200–7.10.1124/jpet.105.09170216174799
126. Schwarz K, Siddiqi N, Singh S, Neil CJ, Dawson DK, Frenneaux MP. The breathing heart – mitochondrial respiratory chain dysfunction in cardiac disease. Int J Cardiol (2014) 171:134–43.10.1016/j.ijcard.2013.12.01424377708
127. Doenst T, Nguyen TD, Abel ED. Cardiac metabolism in heart failure: implications beyond ATP production. Circ Res (2013) 113:709–24.10.1161/CIRCRESAHA.113.30037623989714
128. Rosca MG, Tandler B, Hoppel CL. Mitochondria in cardiac hypertrophy and heart failure. J Mol Cell Cardiol (2013) 55:31–41.10.1016/j.yjmcc.2012.09.002
129. Osterholt M, Nguyen TD, Schwarzer M, Doenst T. Alterations in mitochondrial function in cardiac hypertrophy and heart failure. Heart Fail Rev (2013) 18:645–56.10.1007/s10741-012-9346-722968404
130. Fontaine E, Bernardi P. Progress on the mitochondrial permeability transition pore: regulation by complex I and ubiquinone analogs. J Bioenerg Biomembr (1999) 31:335–45.10.1023/A:100547580235010665524
131. Koopman WJ, Nijtmans LG, Dieteren CE, Roestenberg P, Valsecchi F, Smeitink JA, et al. Mammalian mitochondrial complex I: biogenesis, regulation, and reactive oxygen species generation. Antioxid Redox Signal (2010) 12:1431–70.10.1089/ars.2009.274319803744
132. 1 ATP synthase? Mitochondrion (2012) 12:41–5.10.1016/j.mito.2011.04.007
133. Karamanlidis G, Lee CF, Garcia-Menendez L, Kolwicz SC, Jr Suthammarak W, Gong G, et al. Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure. Cell Metab (2013) 18:239–50.10.1016/j.cmet.2013.07.00223931755
134. Pillai VB, Sundaresan NR, Kim G, Gupta M, Rajamohan SB, Pillai JB, et al. Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. J Biol Chem (2010) 285:3133–44.10.1074/jbc.M109.07727119940131
135. Ahn BH, Kim HS, Song S, Lee IH, Liu J, Vassilopoulos A, et al. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc Natl Acad Sci U S A (2008) 105:14447–52.10.1073/pnas.080379010518794531
136. Schlicker C, Gertz M, Papatheodorou P, Kachholz B, Becker CF, Steegborn C. Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J Mol Biol (2008) 382:790–801.10.1016/j.jmb.2008.07.04818680753
137. Chen Y, Zhang J, Lin Y, Lei Q, Guan KL, Zhao S, et al. Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS. EMBO Rep (2011) 12:534–41.10.1038/embor.2011.6521566644
138. Yu W, Dittenhafer-Reed KE, Denu JM. SIRT3 protein deacetylates isocitrate dehydrogenase 2 (IDH2) and regulates mitochondrial redox status. J Biol Chem (2012) 287:14078–86.10.1074/jbc.M112.35520622416140
139. Zeng H, Vaka VR, He X, Booz GW, Chen JX. High-fat diet induces cardiac remodelling and dysfunction: assessment of the role played by SIRT3 loss. J Cell Mol Med (2015) 19:1847–56.10.1111/jcmm.1255625782072
140. Hafner AV, Dai J, Gomes AP, Xiao CY, Palmeira CM, Rosenzweig A, et al. Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging (Albany NY) (2010) 2:914–23.21212461
141. Porter GA, Urciuoli WR, Brookes PS, Nadtochiy SM. SIRT3 deficiency exacerbates ischemia-reperfusion injury: implication for aged hearts. Am J Physiol Heart Circ Physiol (2014) 306:H1602–9.10.1152/ajpheart.00027.201424748594
142. Parodi-Rullan R, Barreto-Torres G, Ruiz L, Casasnovas J, Javadov S. Direct renin inhibition exerts an anti-hypertrophic effect associated with improved mitochondrial function in post-infarction heart failure in diabetic rats. Cell Physiol Biochem (2012) 29:841–50.10.1159/00017852622613984
143. Moreno-Lastres D, Fontanesi F, Garcia-Consuegra I, Martin MA, Arenas J, Barrientos A, et al. Mitochondrial complex I plays an essential role in human respirasome assembly. Cell Metab (2012) 15:324–35.10.1016/j.cmet.2012.01.01522342700
144. Rosca MG, Vazquez EJ, Kerner J, Parland W, Chandler MP, Stanley W, et al. Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation. Cardiovasc Res (2008) 80:30–9.10.1093/cvr/cvn18418710878
145. Rosca MG, Hoppel CL. Mitochondria in heart failure. Cardiovasc Res (2010) 88:40–50.10.1093/cvr/cvq240
146. Miwa S, Jow H, Baty K, Johnson A, Czapiewski R, Saretzki G, et al. Low abundance of the matrix arm of complex I in mitochondria predicts longevity in mice. Nat Commun (2014) 5:3837.10.1038/ncomms483724815183
147. Jonas EA, Porter GA, Jr Beutner G, Mnatsakanyan N, Alavian KN. Cell death disguised: the mitochondrial permeability transition pore as the c-subunit of the F1FO ATP synthase. Pharmacol Res (2015) 99:382–92.10.1016/j.phrs.2015.04.01325956324
148. Hirst J, Carroll J, Fearnley IM, Shannon RJ, Walker JE. The nuclear encoded subunits of complex I from bovine heart mitochondria. Biochim Biophys Acta (2003) 1604:135–50.10.1016/S0005-2728(03)00059-812837546
149. Carroll J, Fearnley IM, Shannon RJ, Hirst J, Walker JE. Analysis of the subunit composition of complex I from bovine heart mitochondria. Mol Cell Proteomics (2003) 2:117–26.10.1074/mcp.M300014-MCP20012644575
150. Vinothkumar KR, Zhu J, Hirst J. Architecture of mammalian respiratory complex I. Nature (2014) 515:80–4.10.1038/nature1368625209663
151. Lu H. The Study of GRIM-19 Function in Mitochondria. Ph.D., Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore (2007).
152. Babot M, Labarbuta P, Birch A, Kee S, Fuszard M, Botting CH, et al. ND3, ND1 and 39kDa subunits are more exposed in the de-active form of bovine mitochondrial complex I. Biochim Biophys Acta (2014) 1837:929–39.10.1016/j.bbabio.2014.02.01324560811
153. Tocilescu MA, Zickermann V, Zwicker K, Brandt U. Quinone binding and reduction by respiratory complex I. Biochim Biophys Acta (2010) 1797:1883–90.10.1016/j.bbabio.2010.05.00920493164
154. Baradaran R, Berrisford JM, Minhas GS, Sazanov LA. Crystal structure of the entire respiratory complex I. Nature (2013) 494:443–8.10.1038/nature1187123417064
155. Efremov RG, Baradaran R, Sazanov LA. The architecture of respiratory complex I. Nature (2010) 465:441–5.10.1038/nature0906620505720
156. Angerer H, Nasiri HR, Niedergesass V, Kerscher S, Schwalbe H, Brandt U. Tracing the tail of ubiquinone in mitochondrial complex I. Biochim Biophys Acta (2012) 1817:1776–84.10.1016/j.bbabio.2012.03.02122484275
157. Chen YR, Zweier JL. Cardiac mitochondria and reactive oxygen species generation. Circ Res (2014) 114:524–37.10.1161/CIRCRESAHA.114.30055924481843
158. Chen Q, Moghaddas S, Hoppel CL, Lesnefsky EJ. Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria. Am J Physiol Cell Physiol (2008) 294:C460–6.10.1152/ajpcell.00211.200718077608
159. Lu H, Cao X. GRIM-19 is essential for maintenance of mitochondrial membrane potential. Mol Biol Cell (2008) 19:1893–902.10.1091/mbc.E07-07-068318287540
160. Huang G, Lu H, Hao A, Ng DC, Ponniah S, Guo K, et al. GRIM-19, a cell death regulatory protein, is essential for assembly and function of mitochondrial complex I. Mol Cell Biol (2004) 24:8447–56.10.1128/MCB.24.19.8447-8456.200415367666
161. Palmisano G, Sardanelli AM, Signorile A, Papa S, Larsen MR. The phosphorylation pattern of bovine heart complex I subunits. Proteomics (2007) 7:1575–83.10.1002/pmic.20060080117443843
162. Morais VA, Haddad D, Craessaerts K, De Bock PJ, Swerts J, Vilain S, et al. PINK1 loss-of-function mutations affect mitochondrial complex I activity via NdufA10 ubiquinone uncoupling. Science (2014) 344:203–7.10.1126/science.124916124652937
163. Drose S, Brandt U, Wittig I. Mitochondrial respiratory chain complexes as sources and targets of thiol-based redox-regulation. Biochim Biophys Acta (2014) 1844:1344–54.10.1016/j.bbapap.2014.02.00624561273
164. Babot M, Galkin A. Molecular mechanism and physiological role of active-deactive transition of mitochondrial complex I. Biochem Soc Trans (2013) 41:1325–30.10.1042/BST2013008824059527
165. Babot M, Birch A, Labarbuta P, Galkin A. Characterisation of the active/de-active transition of mitochondrial complex I. Biochim Biophys Acta (2014) 1837:1083–92.10.1016/j.bbabio.2014.02.01824569053
166. Ciano M, Fuszard M, Heide H, Botting CH, Galkin A. Conformation-specific crosslinking of mitochondrial complex I. FEBS Lett (2013) 587:867–72.10.1016/j.febslet.2013.02.03923454639
167. Galkin A, Moncada S. S-nitrosation of mitochondrial complex I depends on its structural conformation. J Biol Chem (2007) 282:37448–53.10.1074/jbc.M70754320017956863
168. Chouchani ET, Methner C, Nadtochiy SM, Logan A, Pell VR, Ding S, et al. Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I. Nat Med (2013) 19:753–9.10.1038/nm.321223708290
169. Gorenkova N, Robinson E, Grieve DJ, Galkin A. Conformational change of mitochondrial complex I increases ROS sensitivity during ischemia. Antioxid Redox Signal (2013) 19:1459–68.10.1089/ars.2012.469823419200
170. Han J, Yu C, Souza RF, Theiss AL. Prohibitin 1 modulates mitochondrial function of Stat3. Cell Signal (2014) 26:2086–95.10.1016/j.cellsig.2014.06.00624975845
171. 2+ and membrane potential, an alternative pathway for Interleukin 6 to regulate CD4 cell effector function. Elife (2015) 4:e06376.10.7554/eLife.06376